local_hospital

Diakonhjemmet Sykehus AS

Address
lock Available on a paid plan

Cardiovascular Disease Research

At Diakonhjemmet Sykehus AS in Oslo, clinical trials in cardiovascular diseases focus on improving care for people with chronic heart failure. The research is evaluating whether iron treatment can help reduce serious outcomes such as worsening heart failure and hospital stays.

  • Testing a treatment approach for symptomatic chronic heart failure
  • Assessing whether intravenous iron can improve cardiovascular outcomes
  • Comparing treatment effectiveness for patients with iron deficiency

This work aims to strengthen everyday heart failure management by finding better ways to support patients with complex symptoms and low iron levels.

Immune System and Rheumatology Studies

Research in immune system diseases at this hospital centers on rheumatoid arthritis. The trials are designed to improve disease control, reduce flare-ups, and compare treatment strategies that may help patients stay in remission longer.

  • Evaluating therapeutic drug monitoring for sustained control in rheumatoid arthritis
  • Measuring remission rates in patients with active inflammatory disease
  • Comparing conventional and biologic therapies for better symptom control

The overall goal is to refine treatment choices for people living with rheumatoid arthritis and support more personalized care.

Musculoskeletal Disease Research

Clinical studies in musculoskeletal diseases are addressing conditions such as erosive hand osteoarthritis, hip fracture, and carpal tunnel syndrome. These trials explore ways to ease pain, improve recovery, and choose the most effective treatment pathway for patients.

  • Studying pain relief options for erosive hand osteoarthritis
  • Comparing treatment strategies after hip fracture
  • Assessing management approaches for carpal tunnel syndrome

This area of research combines symptom relief with recovery-focused care, helping clinicians identify practical options for common joint, bone, and nerve-related problems.

Nervous System and Orthopedic Care

Trials related to nervous system diseases at Diakonhjemmet Hospital include work on carpal tunnel syndrome, a condition that can cause pain, numbness, and reduced hand function. The studies are looking at whether less invasive care can perform as well as surgery in selected patients.

  • Evaluating treatment strategies for carpal tunnel syndrome
  • Comparing injection-based care with surgery
  • Measuring patient outcomes after different treatment pathways

These studies aim to improve decision-making for nerve compression disorders by finding effective options that may reduce the need for immediate surgery.

Bone Health and Fracture Recovery

Another important focus is recovery after hip fracture, where researchers are studying ways to support bone health after surgery. The trials examine whether earlier treatment can be as effective as later treatment in helping restore bone stability.

  • Studying post-surgical care for hip fracture
  • Evaluating bone-strengthening treatment timing
  • Supporting recovery and long-term fracture management

This research is intended to improve rehabilitation and reduce future bone-related complications in older adults and other vulnerable patients.

Site Overview

assignment
10
connected trials
corporate_fare
11
sponsors
science
20
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
10
Total trials linked
Highly Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 4 therapeutic areas and 15 of 20 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
5
Sponsors (total)
11
Active sponsors
7

Sponsor Network

Top 7 by active trials.

lock +6 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +2 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 112 other sites in Norway

description
Trial volume
10
Outperforms 79% of sites
public
Therapeutic diversity
4areas
Outperforms 74% of sites
groups
Sponsor diversity
11sponsors
Outperforms 82% of sites

Therapeutic Area Benchmark — Norway

Select a therapeutic area to compare against other sites in Norway.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Norway

Market Share

Country: Norway

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Diakonhjemmet Sykehus AS

lock Showing 1 of 10 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Comparative Study of Triamcinolone Acetonide and Triamcinolone Hexacetonide Injection Strategies Versus Surgical Intervention in Carpal Tunnel SyndromeDiakonhjemmet Sykehus ASPhase IIINot RecruitingApr 2022

IMP list

lock Showing 1 of 20 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Methotrexate2Unknown2024-02-092024-06-20

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.